In Memoriam

Please celebrate the lives and accomplishments of our distinguished members. The obituaries are posted alphabetically and can be found within the tabs below.

Recent

Thomas Hanlon, 1919-2016 (PDF 80Kb)

Dr. Hanlon had a career-long association with Friends Research Institute and resigned his faculty position in 1991 to devote full time to this foundation. He participated in early-treatment evaluation studies on the effectiveness of opioid antagonists in the treatment of heroin addiction, and was involved in designing and conducting numerous psychosocial outpatient treatment trials involving adults with substance use disorders under probation and/or parole supervision.

Robert Spitzer, 1932-2015 (PDF 112Kb)

Perhaps Spitzer's most famous achievement was the removal of the diagnosis of homosexuality as a mental disorder. In the early 70's after meeting with gay-rights advocates, he examined the evidence for homosexuality as a pathologic condition. The issue was extremely contentious, but, in 1973, ultimately he concluded that there was no evidence to support same-sexual orientation as a pathologic condition.

Loren Parsons, 1964-2016 (PDF 53Kb)

Larry's approach to science was admirable. His data were derived from meticulous methodologies, his results were interpreted with insight, and his publications were carefully composed to convey meanings that were simultaneously conservative and progressive. His breadth and depth of knowledge, coupled with fast intellectual processing, enabled him to interact with myriad collaborators and trainees.

Louis Lemberger, 1937-2016 (PDF 44Kb)

His productivity before and during his time at the National Institute of Mental Health was a springboard from which he ascended to prominence in the pharmaceutical industry and as an International leader in the fields of pharmacology, clinical pharmacology, experimental biology, and drug development. In his role as a clinical pharmacologist, he was the first to administer a number of important drugs, including Prozac (antidepressant) and pergolide (anti-parkinsonian).

Paul Wender, 1934-2016 (PDF 46Kb)

Most would place the burgeoning of Paul's career with his 1971 monograph demonstrating the reality of minimal brain dysfunction (MDD) in disturbed children. Further, against the conventional wisdom, genetic causality linked to a dopaminergic deficit was advocated. The MBD label fit the available data better than the still dubious causual implications of attentional disorder. His controlled studies uniquely concluded that MBD did not stop at puberty, but often continued into adulthood.

Fridolin Sulser, 1927-2016 (PDF 116Kb)

Fridolin championed the theory that acute effects of tricylic antidepressant drugs were not directly responsible for thier therapeutic action. His research on the mechanism for the delayed effect of antidepressants was influenced by his friend and Nobel Prize winner, Earl Sutherland, who suggested that he should look beyond the synapse at the norepinephrine/adenylate cyclase signal transduction cascade. This strategy led to the discovery that antidepressant treatments (tricyclics, MAO inhibitors, and ECT), given on a clinically relevant time basis, reduced the responsiveness of the B-adrenoceptor-coupled adenylate cyclase system to norepinephrine in limbic and cortical structures of the rat brain.

Lori Altshuler, 1957-2015 (PDF 251Kb)

Lori had an unparalleled intellectual curiosity, analytical mind, as well as a warm and engaging personality. She formed friendly collegial relationships with equally driven academics in three distinct fields: (1) using neuroimaging to assess underlying causes of mood disorders; (2) conducting clinical trials to assess treatments for bipolar disorder; (3) investigating mood disorders in women during pregnancy, postpartum, and postmenopause.

Athina Markou, 1961-2016 (PDF 59Kb)

'Special' is the word that comes most readily to mind when remembering Athina Markou. Our field lost a special person when Professor Athina Markou passed away on 18 May 2016, at home with her husband and Greek relatives, after a 4-year battle with cancer. In a life well lived, albeit too short, Athina accomplished a great deal, most visably in her Neuropsychopharmacology career. But Athina was much more than a scientist: there was Athina the Greek citizen; Athina the adventurer; Athina the skier; Athina the balletomane; and Athina the friend/mentor/wife.

Barbara Fish, 1920-2016 (PDF 48Kb)

Barbara Fish was the singular child psychiatrist among the founding members of the ACNP and a lead researcher of new psychotropics in children in the NIMH Early Clinical Drug Evaluation Units program. She remained a clinician researcher in a full-time academic career, treating the more severely ill children and training many of today's active child psychiatrists.

Joel Elkes, 1913-2015 (PDF 146Kb)

Joel Elkes, a founding member and first president of the American College of Neuropsychopharmacology, passed away on 30 October 2015. He remained active in the ACNP for over 50 years initiating the Joel Elkes young scientist research award in 1986. His pioneering achievements have led to receipt of many awards and the accolade 'Father of Neuropsychopharmacology'. He was a scientist, mentor, humanistic educator, and an artist.
 

Annual Meeting

Program CoverThe ACNP Annual Meeting is one of the world's leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs.

Research Discussions

This forum enables discussion of articles that have appeared in Neuropsychopharmacology. It is intended to stimulate scholarly interactions among researchers, and to help educate members of the public who are interested in psychiatric illness.

ACNP Publications

Program CoverThe College offers a variety of Publications with the latest and most comprehensive research in psychopharmacology and related fields.